Addus 2024 Earnings: Growth Stumbles Amid Debt and Integration Woes
On February 24, 2025, Addus HomeCare Corporation, a leading provider of home-based personal care, nursing and rehabilitative therapy services, released its financial results for the fourth quarter and full year (FY) ended December 31, 2024, after the market close. The results? Not terrible, but don’t break out the champagne either. Addus Q4 and FY 2024 Financial Snapshot: Metric Q4 2024 Q4 2023 FY 2024 FY 2023 Revenue $297.1 million $276.4 million $1.15 billion $1.06 billion Net Income $19.5 million $19.6 million $73.6 million $62.5 million Net Income per Diluted... Read More »
DOGE Finds $2.7 Trillion in Improper Payments: Healthcare’s Wake-Up Call
The Department of Government Efficiency (DOGE) revealed during a DOGE subcommittee hearing on February 12 that since 2003, the U.S. government has issued $2.7 trillion in improper payments across various federal agencies, including Medicare and Medicaid. While a precise breakdown for these programs was not provided, Medicare and Medicaid have consistently been a source of improper payments among federal programs, raising concerns about the long-term security of federal healthcare spending. In 2023 alone, the Department of Health and Human Services (HHS) reported approximately $100 billion in improper payments tied to Medicare and Medicaid. A critical area of concern lies within the durable... Read More »
Exploring the MedSpa M&A Market: Trends, Drivers and 2025 Outlook
Medical spas, or MedSpas, are hybrid establishments combining the luxury of a traditional spa with medical-grade aesthetic procedures. As an intersection of health, beauty and medicine, MedSpas have seen a surge in popularity in recent years. As wellness and aesthetic care continue to gain prominence in the daily lives of millions, the medical spa sector has become a focal point for M&A, reflecting a robust market landscape poised for further growth. The MedSpa sector’s prominence was evident at various healthcare conferences attended by the LevinPro HC team in 2024. During McGuireWoods’ 17th Annual Healthcare Finance and Growth Conference in September 2024, Eugene Goldenberg of... Read More »
PwC’s Behind the Numbers of Medical Costs
PwC’s Health Research Institute published an article in early January 2025 that projects commercial healthcare spending growth will hit a 13-year high in 2025, with an 8% increase in the Group market and 7.5% in the Individual market. This is driven by inflation, the rising cost of prescription drugs and increased behavioral health utilization. Updated 2023 and 2024 trends reveal higher-than-expected costs due to increased use of GLP-1 drugs and deferred pandemic care. While cost-saving measures like biosimilars offer some relief, they do not counter the increasing expenses. The report highlights the need for healthcare organizations to develop strategies that balance cost... Read More »
Fourth Quarter 2024 Healthcare M&A Volume Slides
In the fourth quarter of 2024, healthcare M&A volume took a plunge, according to data captured in the LevinPro HC platform. Activity declined by 10% compared with volume in Q3:24, falling from 504 announced transactions to just 452. Compared with the fourth quarter of 2023, results looked even worse, falling 13% from 521 deals. It’s worth noting these are preliminary results, as more deals and transactions could surface in the upcoming quarterly and annual reports. Total spending also fell in the fourth quarter, sinking to $31.4 billion compared with $44.8 billion in the third quarter. Q4 was not without some significant transactions price-wise, but nothing hit more than $5 billion in... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
